Anglo American Leads Business Community With Pledge to the UK Matching Fund for Immunisation to Support GAVI

LONDON, June 9, 2011 -

Anglo American today pledged $3 million to the UK Government led
matching initiative for the Global Alliance for Vaccines and
Immunisations (GAVI) - a public/private partnership dramatically
increasing access to immunisation in the world's poorest countries.

Anglo American is the first UK plc to participate in the GAVI Matching
Fund for Immunisation, launched today by the International Development
Secretary, Andrew Mitchell and the Chancellor, George Osborne. The UK
Government has also committed to matching funds raised from Anglo
American employees and suppliers as part of the initiative.

Cynthia Carroll, Chief Executive of Anglo American, commented:

"Anglo American is delighted to announce its commitment of $1 million a
year for three years to the UK Government led Matching Fund initiative
for GAVI. We hope that our action will encourage a similar level of
support for GAVI from other large companies in the UK and around the
world. We are also actively encouraging our employees and suppliers to
participate in this important initiative.

"With approximately 95% of our operations in developing countries,
Anglo American has a deep appreciation of the vital role health plays
in ensuring human development and promoting economic growth."

Anglo American strongly believes that a collective and innovative
response is required from business in order to have a meaningful impact
on improving access to healthcare in developing countries. At the G20
Business Summit in Seoul in November 2010, Anglo American announced a
$3 million pledge over three years to the Global Fund to Fight AIDS,
Tuberculosis and Malaria (The Global Fund) and called on businesses
around the world to do the same.

"The scale of the burden of disease in developing countries demands a
coordinated response between governments, the private sector and civil
society. Anglo American is committed to supporting innovative health
financing partnerships like GAVI and the Global Fund, which are
tackling these significant healthcare challenges with extraordinary
success," Cynthia Carroll said.

Dr Brian Brink, Chief Medical Officer, Anglo American, based
in South Africa, commented:

"Since 2000, GAVI funded vaccines have immunised 288 million
children and prevented more than 5 million deaths. Global Fund sponsored
programs have saved 6.5 million lives and provided access to treatment for
more than 3 million AIDS patients and 7.7 million Tuberculosis patients.
Malaria may be eliminated as a public health problem by 2015, largely as a
result of Global Fund investments. By supporting both these institutions,
Anglo American is a leading business contributor to improving health in
countries with the greatest need.

"Despite these remarkable achievements, funding shortfalls
remain. We urge the private sector to recognise the importance of investing
in health in developing countries; there are significant long-term business
benefits in terms of economic growth and development. For Anglo American,
improving access to healthcare is an important part of our sustainable
development programme, which aims to make a real and lasting difference in
the communities where our mines operate."

Notes to editors

Further information about Anglo American's health programmes

- In 2002, Anglo American was the first major employer to
begin offering free antiretroviral treatment to all its employees and, in
December 2008, Anglo American extended this benefit to employees' direct
dependants. This decision was based largely on the understanding that
HIV/AIDS cannot be effectively managed when only one family member receives
care for a disease that affects the whole family.

- Anglo American's world-leading HIV/AIDS response, providing
the largest free HIV and AIDS workplace and voluntary counselling and testing
(VCT) programme, has been held up as best practice by the Global Business
Coalition on HIV/AIDS, Tuberculosis and Malaria.

- Anglo American's 2009 international employee HIV/AIDS
campaign detailed the company's response in the areas of eliminating the
stigma and discrimination related to the disease. The programme also focuses
on preventing new infections, the provision of care and confidential support
for employees and their dependants infected with and affected by HIV/AIDS,
and managing and mitigating the impact of HIV/AIDS on operations. In so
doing, Anglo American is making a positive contribution towards minimising
the social, economic and developmental consequences of the epidemic.

- Workplace programmes are in place at all Group operations
and business units, with activity particularly focused in southern Africa,
where HIV prevalence figures are estimated at 18% of the region's workforce.

- In 2011, Anglo American co-sponsored the Frontline Heroes in
Health award with Virgin Unite which was presented at GBC Health's 10th
Anniversary Conference and Awards. The award recognises leadership in
community healthcare and was this year presented to Kgomotso Kwenje and Dr
Gilbert Khosa who co-manage the Bhubezi Community Health Centre in South
Africa.

- Bhubezi Community Health Centre, located in Bushbuckridge,
Mpumalanga, in South Africa, is the result of collaboration between the
community, government and business. Supported by USAID / PEPFAR (the U.S.
President's Emergency Plan for AIDS Relief), the South African Department of
Health, Ndlovu Care Group, Anglo American and Virgin Unite, Bhubezi Community
Health Centre is the first to offer basic and specialised healthcare in the
region. Since its establishment in 2007 it has received more than 130,000
patients and provided more than 3,500 HIV positive patients with
anti-retroviral treatment.

- Anglo American's recent progress was rewarded by the Global
Business Coalition (GBC) on HIV/AIDS, Tuberculosis and Malaria at the
organisation's Business Excellence Awards in June 2009, where the company's
Thermal Coal business was recognised as having the best HIV/AIDS workplace
programme in the world.

- The GBC Awards are earned by companies that have
demonstrated extraordinary commitment, action and results, and have achieved
exceptional success in putting their assets to work in the fight against
HIV/AIDS, tuberculosis and malaria.

- Anglo American's Thermal Coal business received the top
award in the 'Workplace Category' for its holistic approach to HIV/AIDS and
was commended by the judges for "its comprehensive, robust and evidence-based
approach to managing HIV and AIDS in the workplace; coupled with the
outstanding leadership and commitment of the company's management and
leadership team."

- Combating HIV/AIDS, Malaria and other diseases is one of the
eight United Nations Millennium Development Goals (MDG) and 2010 represents
an important milestone in the progress of this initiative.

About Anglo American

Anglo American plc is one of the world's largest mining
companies, is headquartered in the UK and listed on the London and
Johannesburg stock exchanges. Anglo American's portfolio of mining businesses
spans precious metals and minerals - in which it is a global leader in both
platinum and diamonds; base metals - copper and nickel; and bulk commodities
- iron ore, metallurgical coal and thermal coal. Anglo American is committed
to the highest standards of safety and responsibility across all its
businesses and geographies and to making a sustainable difference in the
development of the communities around its operations. The company's mining
operations and extensive pipeline of growth projects are located in southern
Africa, South America, Australia, North America and Asia.
www.angloamerican.com

For further information on Anglo American, please contact:

    Media

    UK

    James Wyatt-Tilby
    Tel: +44(0)20-7968-8759

    Emily Blyth
    Tel: +44(0)20-7968-8481

    Investors

    UK 

    Caroline Metcalfe
    Tel: +44(0)20-7968-2192

    Leisha Wemyss
    Tel: +44(0)20-7968-8607

.